1-5 of 5
Philip Imus
Close
Sort by
Journal Articles

A Phase IB/II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or Marrow Transplant (alloBMT) Remission Maintenance

Jonathan Allen Webster, Richard J. Jones, Amanda Blackford, Audra Shedeck, Richard F. Ambinder, Lode J. Swinnen, Nina Wagner-Johnston, Ephraim Joseph Fuchs, Javier Bolanos-Meade, Philip Imus, Challice L. Bonifant, Heather Jill Symons, Tania Jain, Gabrielle T. Prince, Mark J. Levis, Leo Luznik, Ivana Gojo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3582.
https://doi.org/10.1182/blood-2023-191047
Published: 2023
Journal Articles

A Phase I Trial of Activated Donor-Derived Marrow Infiltrating Lymphocytes to Treat Relapsed Hematologic Malignancies after Allogeneic Transplantation with Post-Transplantation Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis

Joseph Rimando, Francesco Mazziotta, Alison Gareau, Maria Bettinotti, Jonathan Allen Webster, Syed Abbas Ali, Philip Imus, Mario Victor Lemas, Amy E. DeZern, Mark J. Levis, Marianna Zahurak, Ravi Varadhan, Richard F. Ambinder, Carol Huff, Ivana Gojo, Richard J. Jones, Ivan M. Borrello, Leo Luznik
Journal: Blood
Blood (2023) 142 (Supplement 1): 3473.
https://doi.org/10.1182/blood-2023-179394
Published: 2023
Journal Articles

The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704

Andrew Artz, Brent R. Logan, Wael Saber, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Tammy Schuler, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Mohamed Sorror
Journal: Blood
Blood (2023) 142 (Supplement 1): 109.
https://doi.org/10.1182/blood-2023-173855
Published: 2023
Journal Articles

Immunoglobulin Heavy Chain Variable Region (IgHV) Unmutated, but Not Mutated, Chronic Lymphocytic Leukemia (CLL) Arises in a CD34+ Progenitor

Brandy Perkins, Margaret M. Showel, MD, Laura Schoch, MS, NP, Philip Imus, MD, Gabriel Ghiaur, MD PhD, Douglas E. Gladstone, MD, Richard J. Jones, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1709.
https://doi.org/10.1182/blood.V130.Suppl_1.1709.1709
Published: 2017
Journal Articles

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Jordan M. Schecter, MD, Daniela Hoehn, MD, PhD, Philip Imus, MD, Eleonora Alma, BS, Suzanne Lentzsch, MD, PhD, Bachir Alobeid, MD, Manuela Orjuela, MD, ScM, Owen A. O'Connor, MD, PhD, Govind Bhagat, MD
Journal: Blood
Blood (2013) 122 (21): 4333.
https://doi.org/10.1182/blood.V122.21.4333.4333
Published: 2013